Passage Bio Ownership | Who Owns Passage Bio?
Passage Bio Ownership Summary
Passage Bio is owned by 52.03% institutional investors, 0.21% insiders, and 47.76% retail investors. New leaf venture partners is the largest institutional shareholder, holding 2.76% of PASG shares. Worldwide Healthcare Ord is the top mutual fund, with 3.28% of its assets in Passage Bio shares.
PASG Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Passage Bio | 52.03% | 0.21% | 47.76% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| New leaf venture partners | 87.43K | 2.76% | $702.03K |
| Blackrock | 817.53K | 1.45% | $649.28K |
| Millennium management | 148.61K | 0.24% | $84.28K |
| Goldman sachs group | 27.07K | 0.04% | $15.35K |
| Morgan stanley | 13.44K | 0.02% | $10.68K |
| Rhumbline advisers | 783.00 | 0.00% | $621.00 |
| Royal bank of canada | 693.00 | 0.00% | $1.00K |
| Citadel advisors | 400.00 | 0.00% | $318.00 |
| Bank of america corp /de/ | 367.00 | 0.00% | $291.00 |
| Engineers gate manager lp | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| New leaf venture partners | 87.43K | 1.63% | $702.03K |
| Renaissance | - | - | - |
| Two sigma advisers, lp | - | - | - |
| Mariner | - | - | - |
| Engineers gate manager lp | - | - | - |
| Blackrock | 817.53K | - | $649.28K |
| Marshall wace, llp | - | - | - |
| Tower research capital llc (trc) | - | - | - |
| Two sigma securities | - | - | - |
| Geode capital management | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bank of america corp /de/ | 367.00 | - | 366.00 |
| Royal bank of canada | 693.00 | - | 193.00 |
| Rhumbline advisers | 783.00 | - | - |
| Ubs group | - | - | -3.00 |
| Qube research | - | - | -4.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Lynx1 capital management lp | - | - | -9.26M |
| Vestal point capital, lp | - | - | -6.10M |
| Orbimed advisors | - | - | -6.06M |
| Versant venture management | - | - | -4.03M |
| Erste asset management gmbh | - | - | -2.46M |
Sold Out
| Holder | Change |
|---|---|
| Ubs group | -3.00 |
| Qube research | -4.00 |
| Federation des caisses desjardins du quebec | -10.00 |
| Mid-american wealth advisory group | -32.00 |
| Group one trading | -47.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 30 | -23.08% | 1,648,912 | -95.30% | 52 | 1.70% | 9 | -35.71% | 21 | 90.91% |
| Jun 30, 2025 | 39 | -4.88% | 35,055,187 | 3.65% | 55 | 1.87% | 16 | 6.67% | 11 | - |
| Mar 31, 2025 | 42 | -4.55% | 36,319,837 | -3.48% | 58 | 1.58% | 15 | -25.00% | 11 | 10.00% |
| Dec 31, 2024 | 13 | -70.45% | 6,312,660 | -83.67% | 10 | 0.26% | 5 | -72.22% | 4 | -42.86% |
| Sep 30, 2024 | 44 | - | 38,667,152 | 2.24% | 62 | 1.39% | 19 | 72.73% | 7 | -36.36% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Worldwide Healthcare Ord | 2.03M | 3.28% | - |
| Vanguard US Total Market Shares ETF | 1.50M | 2.41% | - |
| Vanguard Total Stock Mkt Idx Inv | 73.23K | 2.35% | -1.60K |
| Vanguard Institutional Extnd Mkt Idx Tr | 25.59K | 0.82% | 924.00 |
| Bridgeway Ultra-Small Company | 416.04K | 0.67% | - |
| Galileo - Biotech Innovation Fund S USD | 412.28K | 0.65% | - |
| Fidelity Extended Market Index | 14.40K | 0.45% | - |
| iShares Micro-Cap ETF | 101.78K | 0.16% | - |
| Bridgeway Ultra-Small Company Market | 90.10K | 0.14% | -50.00K |
| Fidelity Total Market Index | 4.07K | 0.13% | 1.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 11, 2025 | Lynx1 Capital Management LP | - | Buy | $2.26K |
| Sep 15, 2025 | Lynx1 Capital Management LP | - | Buy | $83.18K |
| Sep 12, 2025 | Lynx1 Capital Management LP | - | Buy | $138.30K |
| Jul 23, 2025 | Lynx1 Capital Management LP | - | Buy | $283.03K |
| Jul 24, 2025 | Lynx1 Capital Management LP | - | Buy | $379.45K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | 6 | - |
| 2025 Q2 | - | 9 |
| 2025 Q1 | - | 7 |
| 2024 Q4 | 4 | 6 |
| 2024 Q3 | - | 4 |
PASG Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools